Baystate Wealth Management’s iShares iBonds Dec 2025 Term Corporate ETF IBDQ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
$110K Sell
4,423
-6
-0.1% -$147 0.01% 265
2023
Q3
$108K Buy
4,429
+16
+0.4% +$390 0.01% 247
2023
Q2
$108K Buy
4,413
+15
+0.3% +$367 0.01% 248
2023
Q1
$108K Buy
4,398
+10
+0.2% +$244 0.01% 242
2022
Q4
$107K Buy
4,388
+4,212
+2,393% +$102K 0.01% 248
2022
Q3
$4K Buy
+176
New +$4.34K ﹤0.01% 662

Other funds holding IBDQ

Baystate Wealth Management's IBDQ Position: Q4 2023 in Review

Baystate Wealth Management reduced its iShares iBonds Dec 2025 Term Corporate ETF (IBDQ) stake by 0.14% in Q4 2023, selling an estimated $147 and leaving 4,423 shares worth $110K. The position accounts for 0.01% of the portfolio, ranked #265.

Baystate Wealth Management first reported a position in IBDQ in Q3 2022 and has held it in 6 quarters since. 325 funds tracked by Wall St. Rank hold IBDQ as of Q4 2023.

  • Baystate Wealth Management held 4,423 shares of iShares iBonds Dec 2025 Term Corporate ETF worth $110K as of Q4 2023.
  • Baystate Wealth Management sold 6 iShares iBonds Dec 2025 Term Corporate ETF shares in Q4 2023, an estimated $147.
  • iShares iBonds Dec 2025 Term Corporate ETF made up 0.01% of Baystate Wealth Management's portfolio in Q4 2023, its #265 holding.
  • Baystate Wealth Management first reported a position in iShares iBonds Dec 2025 Term Corporate ETF in Q3 2022 and has held it in 6 quarters since.
  • 325 funds tracked by Wall St. Rank held iShares iBonds Dec 2025 Term Corporate ETF as of Q4 2023.

Based on Baystate Wealth Management's 13F filing for Q4 2023, filed 29 Jan 2024.